Dr. Reddy's Laboratories, Inc. recalls Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited
Recalled March 20, 2019 · FDA recall D-1001-2019 · Dr. Reddy's Laboratories
Hazard
Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance. · FDA Class II
Units
5,755 vials
Sold at
Nationwide in the USA
Description
Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.
Product
Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, Andhra Pradesh, INDIA, NDC 43598-259-40.
Manufacturer(s)
Dr. Reddy's Laboratories, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →